跳至主要内容
临床试验/NCT06888778
NCT06888778已完成不适用

Efficacy of Deep-coil Based Repetitive Transcranial Magnetic Stimulation in the Treatment of Parkinson's Disease With Freezing of Gait and Its Neural Regulation Mechanism Study of Resting-state Cerebral Blood Flow

Ningbo Medical Center Lihuili Hospital1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2023年2月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
60
试验地点
1
主要终点
Unified Parkinson's Disease Rating Scale

研究概览

简要总结

The protocol for repetitive transcranial magnetic stimulation (rTMS) in treating Parkinson's disease (PD) with freezing of gait (FOG) has not yet established an internationally unified standard, and the heterogeneity of treatment parameters is often the main factor leading to significant differences in efficacy. Based on descriptive analyses and existing data from studies with relatively small sample sizes, the current research primarily focuses on unilateral stimulation targets, without exploring the effectiveness of stimulating the bilateral primary motor centers for lower limbs (M1-LL). Moreover, most studies use figure-of-eight coils or circular coils, while deep-coil stimulation may be more effective for M1-LL. There is still a lack of research employing arterial spin labeling (ASL) imaging to explore the neural mechanisms of resting-state cerebral blood flow (CBF) regulation associated with rTMS treatment for FOG.

Therefore, this research project will focus on improving the above - mentioned issues. The high - frequency stimulation of bilateral M1 - LL using a deep - coil (double - cone coil) will be selected. The sample size will be further expanded to evaluate the efficacy of rTMS in treating freezing of gait (FOG). Combined with the three - dimensional arterial spin labeling (3D - ASL) imaging technique, the changes in resting - state cerebral blood flow (CBF) before and after treatment will be analyzed to explore the possible neural mechanisms of rTMS in treating FOG.

详细描述

Magstim rapid 2 transcranial magnetic stimulation instrument was used with double-cone coils, and the stimulation target was bilateral M1-LL. The total stimulation time of each target was 10 minutes, once a day, 5 times a week (5 consecutive working days), and the treatment was continuous for 2 weeks, a total of 10 times.

Stimulus parameter setting:

  • True stimulus group: 100% Rest Motor Threshold (RMT), 10Hz, each stimulus lasted 10 seconds, 55 seconds apart, a total of 10 strings. Once a day, each side of the lower extremity region of the primary motor cortex received a total of 1000 pulses.
  • In the pseudo-stimulation group, the side of the double-cone coil was placed against the scalp, and the bull 's-eye of the coil was stimulated towards the air. Other treatment parameters were the same as those of true stimulation group.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
45 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Meeting the clinical diagnostic criteria for Parkinson's disease established by the Movement Disorder Society (MDS) in
  • •Aged between 45 and 70 years old, regardless of gender.
  • •Regularly taking anti - Parkinson's disease medications for a long time (≥3 years), accompanied by freezing of gait, and with poor efficacy of medications;
  • •A score of ≥24 on the Mini - Mental State Examination (MMSE).
  • •Signing the informed consent form and being willing to actively cooperate with the treatment.

排除标准

  • •Freezing of gait caused by parkinsonism and parkinson plus syndromes.
  • •Having a history of central nervous system diseases such as cerebral infarction, cerebral hemorrhage, leukoencephalopathy, and migraine.
  • •Having been diagnosed with epilepsy or having had epileptic seizures.
  • •Having undergone craniocerebral surgery, having cerebral aneurysms or arteriovenous malformations, having metal implants in the skull, or having had a cardiac pacemaker implanted.
  • •Having a history of other mental illnesses or a family history of mental illnesses, such as schizophrenia, bipolar disorder, autism, mental retardation, depression, etc.
  • •Having received rTMS treatment.
  • •Severe PD (H&Y grade ≥ 4).
  • •Severe organ dysfunction or severe physical diseases.

研究组 & 干预措施

stimulation group

Experimental

participants receive repetitive transcranial magnetic stimulation (rTMS)

干预措施: repetitive transcranial magnetic stimulation (rTMS) (Other)

Non-stimulation group

Placebo Comparator

participants receive Non-stimulation:The side of the double cone coil is placed against the scalp, and the target of the coil is stimulated in the direction of air.

干预措施: Non-stimulation (Other)

结局指标

主要结局

Unified Parkinson's Disease Rating Scale

时间窗: Within 24 hours before treatment, within 24 hours after treatment, and 1 month after treatment

In this study, Unified Parkinson's Disease Rating Scale(UPDRS) score was used as an assessment tool for PD patients. Four subscales, UPDRS II (0-52 scores), UPDRS III (0-56 scores), UPDRS V (0-5 grades), and UPDRS VI (0-11 grades), were used to assess the condition. The higher the score or grade, the sicker the patient.

次要结局

未报告次要终点

研究者

发起方
Ningbo Medical Center Lihuili Hospital
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Guangli Ren

Associate Director of Neurology

Ningbo Medical Center Lihuili Hospital

研究点 (1)

Loading locations...

相似试验